Third Rock Ventures and Parse Biosciences today announced a strategic collaboration to create an unprecedented atlas of 5 million T cell receptors (TCRs) using Parse Biosciences’ GigaLab platform. The ...
The project launched in 2017 and with a price tag of at least €100 billion, aims to strengthen European defence and will ...